e-learning
resources
Madrid 2019
Tuesday, 01.10.2019
Research and innovation in airway diseases
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Artificial neural networks within the severity stratification of the chronic obstructive pulmonary disease
B. Geltser (Vladivostok, Russian Federation), ?. Shahgeldyan (Vladivostok, Russian Federation), I. Kurpatov (Vladivostok, Russian Federation), V. Kotelnikov (Vladivostok, Russian Federation)
Source:
International Congress 2019 – Research and innovation in airway diseases
Session:
Research and innovation in airway diseases
Session type:
Thematic Poster
Number:
4275
Disease area:
Airway diseases
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
B. Geltser (Vladivostok, Russian Federation), ?. Shahgeldyan (Vladivostok, Russian Federation), I. Kurpatov (Vladivostok, Russian Federation), V. Kotelnikov (Vladivostok, Russian Federation). Artificial neural networks within the severity stratification of the chronic obstructive pulmonary disease. 4275
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Panel discussion on ERS Statement – A core outcome set for clinical trials evaluating the management of COPD exacerbations
ERS statement: a core outcome set for clinical trials evaluating the management of COPD exacerbations
Evidence-based eHealth for COPD
Related content which might interest you:
Functional and neurophysiological aspects in patients with chronic obstructive pulmonary disease
Source: Annual Congress 2011 - Clinical physiology for clinical problems
Year: 2011
The impact of using different symptom-based exacerbation algorithms in patients with COPD
Source: Eur Respir J 2011; 37: 1260-1268
Year: 2011
Analysis of parameters of lung function in patients with severe chronic obstructive pulmonary disease
Source: Eur Respir J 2001; 18: Suppl. 33, 214s
Year: 2001
Change in autonomic functions in patients with chronic obstructive pulmonary disease
Source: Eur Respir J 2002; 20: Suppl. 38, 257s
Year: 2002
Investigating the fatigue and related factors in patients with chronic obstructive pulmonary disease.
Source: International Congress 2017 – Assessing functional outcomes in chronic respiratory disease
Year: 2017
Unrecognised ventricular dysfunction in COPD
Source: Eur Respir J 2012; 39: 51-58
Year: 2012
Unrecognised ventricular dysfunction in COPD
Source: Eur Respir J 2011; 39: 51-58
Year: 2012
Angiogenic status in patients with chronic obstructive pulmonary disease.
Source: Virtual Congress 2020 – Prediction of outcomes in obstructive diseases
Year: 2020
Correlation of severity of chronic obstructive pulmonary disease with potential biomarkers
Source: Virtual Congress 2020 – Clinical characteristics and diagnostic tools for phenotyping asthma and COPD
Year: 2020
Does the severity of chronic obstructive pulmonary disease reflect on the outcomes of pulmonary rehabilitation?
Source: Annual Congress 2007 - Assessment and outcomes in patients with chronic airway obstruction
Year: 2007
Mechanisms of ECG changes in chronic obstructive pulmonary disease
Source: International Congress 2016 – Pulmonary hypertension in lung disease
Year: 2016
Effects of severity of chronic obstructive pulmonary disease on thyroid function
Source: Eur Respir J 2005; 26: Suppl. 49, 509s
Year: 2005
Are severe asthma and chronic obstructive pulmonary disease the same disease?
Source: Annual Congress 2006 - Smoking asthmatics – a neglected population?
Year: 2006
Rhinovirus-infection in chronic obstructive pulmonary disease
Source: Eur Respir J 2002; 20: Suppl. 38, 591s
Year: 2002
Factors associated with chronic obstructive pulmonary disease exacerbation, based on big data analysis
Source: International Congress 2019 – Advances in clinical management of COPD
Year: 2019
Determinants of depression at exacerbation in chronic obstructive pulmonary disease
Source: Eur Respir J 2007; 30: Suppl. 51, 557s
Year: 2007
Inflammation and depression in chronic obstructive pulmonary disease
Source: Eur Respir J 2007; 30: Suppl. 51, 718s
Year: 2007
Acute coronary events during acute exacerbations of chronic obstructive pulmonary disease
Source: Annual Congress 2007 - Clinical aspects in COPD
Year: 2007
Mechanisms in chronic obstructive pulmonary disease: comparisons with asthma
Source: Annual Congress 2008 - PG17 - An expert view of the differences between asthma and COPD
Year: 2008
The difficulties of functional class heart failure assessment in the patients with concomitant chronic obstructive pulmonary disease
Source: Annual Congress 2010 - COPD: cardiovascular comorbidities
Year: 2010
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept